abstract |
The invention relates to a method of treatment of indications which can be positively influenced by inhibition of AT1 mediated effects with maintenance of AT2 receptor mediated effects of Angiotensin II and by ACE inhibition, th us also increasing bradykinin mediated effects, e.g. to reduce the incidence of stroke, acute myocardial infarction or cardiovascular death, or of indicatio ns associated with the increase of AT1 receptors in the sub-epithelial area or increase of AT2 receptors in the epithelia, comprising co-administration of effective amounts of an Angiotensin II antagonist and an ACE inhibitor, pharmaceutical compositions containing an Angiotensin II antagonist together with an ACE inhibitor and the use of an Angiotensin II antagonist and an ACE inhibitor for the manufacture of corresponding pharmaceutical compositions.< /SDOAB> |